Zeller J, Imbeaud S, Rey R, Adamsbaum C, Fourmaintraux A, Donnet J, van Kote G, Josso N, Chaussain J L
Service d'endocrinologie pédiatrique, Hôpital Saint-Vincent-de-Paul, Paris.
Arch Pediatr. 1994 Nov;1(11):991-7.
The persistent müllerian duct syndrome (PMDS) is characterized by the persistence of the uterus and Fallopian tubes in otherwise normally virilized boys. Its diagnosis is usually made during a surgical procedure for inguinal hernia or cryptorchidism. We report six recent cases of PMDS, in which we have studied anti-Müllerian hormone (AMH) serum levels.
Six boys including three brothers were operated on for cryptorchidism or inguinal hernia. Surgical exploration showed persistence of the uterus and Fallopian tubes in patients having normal 46, XY karyotype and male gonads. The AMH serum levels were measured by Elisa and the AMH gene by single strand conformation polymorphism of PCR products.
The three brothers showed a mutation in the AMH gene which leads to the replacement of leucine by proline at position 70 and to a defect in AMH production. In two other patients, serum AMH values were normal, no mutation on the AMH gene was found, and end-organ insensitivity was suggested to explain the persistence of müllerian derivatives. In the last patient, although AMH serum levels were very low due to a progressive degeneration of testicular tissue, molecular analysis of the AMH gene suggested that end-organ resistance might be the cause of the persistence of müllerian ducts.
PMDS is not extremely rare. Many diagnostic mistakes are made which could be prevented by performing pelvic or inguinal ultrasonography before surgical treatment of bilateral cryptorchidism or irreducible inguinal hernia. Prognosis depends upon the integrity of the testicular tissue, sometimes compromised for yet unexplained reasons, and upon the successful correction of cryptorchidism, which is complicated by the close anatomical relationship between the vasa deferentia and the Müllerian derivatives.
持续性苗勒管综合征(PMDS)的特征是在其他方面正常男性化的男孩中子宫和输卵管持续存在。其诊断通常在腹股沟疝或隐睾症的手术过程中做出。我们报告了最近的6例PMDS病例,其中我们研究了抗苗勒管激素(AMH)的血清水平。
6名男孩,包括3名兄弟,因隐睾症或腹股沟疝接受手术。手术探查显示,核型为46,XY且性腺为男性的患者存在子宫和输卵管持续存在的情况。通过酶联免疫吸附测定法(ELISA)测量AMH血清水平,并通过聚合酶链反应(PCR)产物的单链构象多态性分析AMH基因。
3名兄弟的AMH基因发生突变,导致第70位的亮氨酸被脯氨酸取代,AMH产生存在缺陷。另外2名患者的血清AMH值正常,未发现AMH基因突变,提示终末器官不敏感可解释苗勒管衍生物的持续存在。在最后1名患者中,尽管由于睾丸组织进行性退化,AMH血清水平非常低,但AMH基因的分子分析表明终末器官抵抗可能是苗勒管持续存在的原因。
PMDS并非极为罕见。在双侧隐睾症或不可复性腹股沟疝的手术治疗前进行盆腔或腹股沟超声检查可避免许多可能出现的诊断错误。预后取决于睾丸组织的完整性,有时会因不明原因而受损,还取决于隐睾症的成功矫正,这因输精管与苗勒管衍生物之间密切的解剖关系而变得复杂。